References
- Johnson RJ, et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 2007;86(4):899-906.
- Fraulob JC, et al. A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet. J Clin Biochem Nutr 2010;46(3):212-23. https://doi.org/10.3164/jcbn.09-83
- Podrini C, et al. High-fat feeding rapidly induces obesity and lipid derangements in C57BL/6N mice. Mamm Genome 2013;24(5-6):240-51. https://doi.org/10.1007/s00335-013-9456-0
- Dunn W, et al. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 2008;103(9):2263-71. https://doi.org/10.1111/j.1572-0241.2008.02034.x
- Lam B, Younossi ZM. Treatment options for nonalcoholic fatty liver disease. Therap Adv Gastroenterol 2010;3(2):121-37. https://doi.org/10.1177/1756283X09359964
- Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 2008;118(3):829-38. https://doi.org/10.1172/JCI34275
- Masuoka, H.C. and N. Chalasani, Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Ann N Y Acad Sci. 1281: p. 106-122. https://doi.org/10.1111/nyas.12016
- Smith, B.W. and L.A. Adams, Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nat Rev Endocrinol. 7(8): p. 456-465. https://doi.org/10.1038/nrendo.2011.72
- Adams LA, Angulo P. Treatment of non-alcoholic fatty liver disease. Postgrad Med J 2006;82(967):315-22. https://doi.org/10.1136/pgmj.2005.042200
- Nobili V, et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 2008;48(1):119-28. https://doi.org/10.1002/hep.22336
- Chen CC, et al. Peroxisome proliferator-activated receptor gamma transactivation-mediated potentiation of glucose uptake by Bai-Hu-Tang. J Ethnopharmacol 2008;118(1):46-50. https://doi.org/10.1016/j.jep.2008.03.001
- Huang CY, et al. Prescription pattern of Chinese herbal products for diabetes mellitus in taiwan: a population-based study. Evid Based Complement Alternat Med 2013;2013:201329.
- Kimura I, et al. The antihyperglycaemic blend effect of traditional Chinese medicine byakko-ka-ninjin-to on alloxan and diabetic KK-CA(y) mice. Phytother Res 1999;13(6):484-8. https://doi.org/10.1002/(SICI)1099-1573(199909)13:6<484::AID-PTR485>3.0.CO;2-X
- Liu HK, et al. Ginseng-plus-Bai-Hu-Tang decoction reduces fatty liver by activating AMP-activated protein kinase in vitro and in vivo. Evid Base Compl Alternat Med 2015;2015:651734.
- Kawamoto TH, et al. Resting metabolic rates of two orbweb spiders: a first approach to evolutionary success of ecribellate spiders. J Insect Physiol 2011;57(3):427-32. https://doi.org/10.1016/j.jinsphys.2011.01.001
- Suliga E, et al. Factors associated with adiposity, lipid profile disorders and the metabolic syndrome occurrence in premenopausal and postmenopausal women. PLoS One 2016;11(4):e0154511. https://doi.org/10.1371/journal.pone.0154511
- Zambo, V., et al., Lipotoxicity in the liver. World J Hepatol. 5(10): p. 550-557. https://doi.org/10.4254/wjh.v5.i10.550
- Fabbrini E, Magkos F. Hepatic steatosis as a marker of metabolic dysfunction. Nutrients 2015;7(6):4995-5019. https://doi.org/10.3390/nu7064995
- Cassidy WM, Reynolds TB. Serum lactic dehydrogenase in the differential diagnosis of acute hepatocellular injury. J Clin Gastroenterol 1994;19(2):118-21. https://doi.org/10.1097/00004836-199409000-00008
- Dufour DR, et al. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 2000;46(12):2050-68. https://doi.org/10.1093/clinchem/46.12.2050
- Giordano C, et al. Uric acid as a marker of kidney disease: review of the current literature. Dis Markers 2015;2015:382918. https://doi.org/10.1155/2015/382918
- Sato A, et al. Antiobesity effect of eicosapentaenoic acid in high-fat/highsucrose diet-induced obesity: importance of hepatic lipogenesis. Diabetes 2010;59(10):2495-504. https://doi.org/10.2337/db09-1554
- Ling JC, et al. Determinants of high fasting insulin and insulin resistance among overweight/obese adolescents. Sci Rep 2016;6:36270. https://doi.org/10.1038/srep36270
- Xiong, Y., et al., Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats. Diabetes. 59(10): p. 2505-2512. https://doi.org/10.2337/db10-0315
- Park S, et al. Ginsenosides Rb1 and Rg1 suppress triglyceride accumulation in 3T3-L1 adipocytes and enhance beta-cell insulin secretion and viability in Min6 cells via PKA-dependent pathways. Biosci Biotechnol Biochem 2008;72(11):2815-23. https://doi.org/10.1271/bbb.80205
- Shen, L., et al., Ginsenoside Rb1 reduces fatty liver by activating AMPactivated protein kinase in obese rats. J Lipid Res. 54(5): p. 1430-1438. https://doi.org/10.1194/jlr.M035907
- Srinivasan K, et al. Combination of high-fat diet-fed and low-dose streptozotocin- treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 2005;52(4):313-20. https://doi.org/10.1016/j.phrs.2005.05.004
- Yuan G, Al-Shali KZ, Hegele RA. Hypertriglyceridemia: its etiology, effects and treatment. CMAJ 2007;176(8):1113-20. https://doi.org/10.1503/cmaj.060963
- Jialal I, Amess W, Kaur M. Management of hypertriglyceridemia in the diabetic patient. Curr Diab Rep 2010;10(4):316-20. https://doi.org/10.1007/s11892-010-0124-4
- Tomlinson JW, et al. Impaired glucose tolerance and insulin resistance are associated with increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5alpha-reductase activity. Diabetes 2008;57(10):2652-60. https://doi.org/10.2337/db08-0495
- Morimoto A, et al. Increase in homeostasis model assessment of insulin resistance (HOMA-IR) had a strong impact on the development of type 2 diabetes in Japanese individuals with impaired insulin secretion: the Saku study. PLoS One 2014;9(8):e105827. https://doi.org/10.1371/journal.pone.0105827
- Pataky MW, et al. High-fat diet-induced insulin resistance in single skeletal muscle fibers is fiber type selective. Sci Rep 2017;7(1):13642. https://doi.org/10.1038/s41598-017-12682-z
- Hancock CR, et al. High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc Natl Acad Sci U S A 2008;105(22):7815-20. https://doi.org/10.1073/pnas.0802057105
- Cheng J, et al. Loss of Mbd2 protects mice against high-fat diet-induced obesity and insulin resistance by regulating the homeostasis of energy storage and expenditure. Diabetes 2016;65(11):3384-95. https://doi.org/10.2337/db16-0151
- Enomoto H, et al. Liver fibrosis markers of nonalcoholic steatohepatitis. World J Gastroenterol 2015;21(24):7427-35. https://doi.org/10.3748/wjg.v21.i24.7427
- Armutcu F, et al. Markers in nonalcoholic steatohepatitis. Adv Clin Chem 2013;61:67-125. https://doi.org/10.1016/B978-0-12-407680-8.00004-X
- Regev A, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97(10):2614-8. https://doi.org/10.1016/S0002-9270(02)04396-4
- Sharma S, Khalili K, Nguyen GC. Non-invasive diagnosis of advanced fibrosis and cirrhosis. World J Gastroenterol 2014;20(45):16820-30. https://doi.org/10.3748/wjg.v20.i45.16820
Cited by
- Effect of Korean Red Ginseng through comparative analysis of cardiac gene expression in db/db mice vol.45, pp.3, 2020, https://doi.org/10.1016/j.jgr.2020.06.001
- Effect of Korean Red Ginseng on metabolic syndrome vol.45, pp.3, 2020, https://doi.org/10.1016/j.jgr.2020.11.002
- The effects of ginseng on the metabolic syndrome: An updated review vol.9, pp.9, 2021, https://doi.org/10.1002/fsn3.2475